EVALUATION AND MANAGEMENT OF POSTPARTUM HYPERTENSION IN A TERTIARY CARE HOSPITAL

Authors

  • SETUMA MISHRA Department of Obstetrics and Gynaecology, Government Medical College and Rajindra Hospital, Patiala, Punjab, India.
  • Parneet Kaur Department of Obstetrics and Gynaecology, Government Medical College and Rajindra Hospital, Patiala, Punjab, India.
  • SATINDER PAL KAUR Department of Obstetrics and Gynaecology, Government Medical College and Rajindra Hospital, Patiala, Punjab, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i10.47925

Keywords:

Postpartum hypertension, Chronic hypertension, Preeclampsia

Abstract

Objective: The objective is to study the causative factors of postpartum hypertension (PPHTN), time taken for control of blood pressure (BP) in postpartum period and to study the anti-hypertensive drugs used in control of PPHTN.

Methods: The study was conducted for 1½ years. During the study, 190 women in postpartum period with high BP were enrolled in the study. A detailed record of history and general physical examination and local examination was done as per pro forma after written informed consent.

Results: Out of 190 subjects, 168 had a history of hypertension (HTN) in the antenatal period, and the rest 22 went on to develop HTN in the postpartum period. Gestational HTN and preeclampsia were the most frequent types of hypertensive disorders seen among subjects. In 42.1% of patients, PPHTN developed after 48 h and in 23.7% of cases developed within 48 h. BP normalized post-delivery in 22.6% of subjects. The majority (74.1%) of subjects took tablet labetalol post-delivery. 62.1% of patients took anti-hypertensive for more than 7 days and were discharged on treatment with advice to follow-up. 15.3% took treatment for <7 days. No treatment was required by 22.6% of subjects.

Conclusion: Our data identified a high prevalence of PPHTN. We found a significant correlation between the levels of severity of antepartum BP with the level of severity of postpartum BP. Monitoring of HTN is important in the postpartum period for all patients as the majority develop hypertension after 48 h.

Downloads

Download data is not yet available.

References

Goldenberg RL, McClure EM, Macguire ER, Kamath BD, Jobe AH. Lessons for low-income regions following the reduction in hypertension-related maternal mortality in high-income countries. Int J Gynaecol Obstet 2011;113:91-5. doi: 10.1016/j.ijgo.2011.01.002, PMID: 21349517

Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol 2012;206:470-5. doi: 10.1016/j. ajog.2011.09.002, PMID: 21963308

Sharma KJ, Kilpatrick SJ. Postpartum hypertension: Etiology, diagnosis, and management. Obstet Gynecol Surv 2017;72:248-52. doi: 10.1097/OGX.0000000000000424, PMID: 28426127

Podymow T, August P. Postpartum course of gestational hypertension and preeclampsia. Hypertens Pregnancy 2010;29:294-300. doi: 10.3109/10641950902777747, PMID: 20670153

Hu X, Zhang L. Uteroplacental circulation in normal pregnancy and preeclampsia: Functional Adaptation and maladaptation. Int J Mol Sci 2021; 22:8622. https://doi.org/10.3390/ijms22168622, PMID: 34445328, PMCID: PMC8395300

Chandiramani MA, Shennan AH, Waugh JJ. Modern management of postpartum hypertension. Trends Urol Gynaecol Sex Health 2007;12:37-42.

National Collaborating Centre for Women’s and Children’s Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders during Pregnancy. London: RCOG Press; 2010. PMID: 22220321

Magee L, von Dadelszen P. Prevention and treatment of postpartum hypertension. Cochrane Database Syst Rev 2013;4:CD004351. doi: 10.1002/14651858.CD004351.pub3, PMID: 23633317

Hypertension in pregnancy. Report of the American college of obstetricians and gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol 2013;122:1122-31. doi: 10.1097/01. AOG.0000437382.03963.88, PMID: 24150027

Viteri OA, Alrais MA, Pedroza C, Hutchinson M, Chauhan SP, Blackwell SC, et al. Torsemide for prevention of persistent postpartum hypertension in women with preeclampsia: A randomized controlled trial. Obstet Gynecol 2018;132:1185-91. doi: 10.1097/ AOG.0000000000002941, PMID: 30303905

Mogos MF, Salemi JL, Spooner KK, McFarlin BL, Salihu HH. Hypertensive disorders of pregnancy and postpartum readmission in the United States: National surveillance of the revolving door. J Hypertens 2018;36:608-8. doi: 10.1097/HJH.0000000000001594, PMID: 29045342

Ainuddin J, Javed F, Kazi S. Oral labetalol versus oral nifedipine for the management of postpartum hypertension a randomized control trial. Pak J Med Sci 2019;35:1428-33. doi: 10.12669/pjms.35.5.812, PMID: 31489020; PMCID: PMC6717493

Vigil-De Gracia P, Ruiz E, López JC, de Jaramillo IA, Vega- Maleck JC, Pinzón J. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: A randomized clinical trial. Hypertens Pregnancy 2007;26:163-71. doi: 10.1080/10641950701204430, PMID: 17469006

Reddy M, Rolnik DL, Harris K, Li W, Mol BW, Da Silva Costa F, et al. Challenging the definition of hypertension in pregnancy: a retrospective cohort study. Am J Obstet Gynecol 2020;222:606.e1-21. doi: 10.1016/j. ajog.2019.12.272, PMID: 31954700

Hauspurg A, Lemon LS, Quinn BA, Binstock A, Larkin J, Beigi RH, et al. A postpartum remote hypertension monitoring protocol implemented at the hospital level. Obstet Gynecol 2019;134:685-91. doi: 10.1097/AOG.0000000000003479, PMID: 31503166; PMCID: PMC7289450

Ishaku SM, Jamilu T, Innocent AP, Gbenga KA, Lamaran D, Lawal O, et al. Persistent hypertension up to one year postpartum among women with hypertensive disorders in pregnancy in a low-resource setting: A prospective cohort study. Glob Heart 2021;16:62. doi: 10.5334/ gh.854. PMID: 34692386; PMCID: PMC8428291

Goel A, Maski MR, Bajracharya S, Wenger JB, Zhang D, Salahuddin S, et al. Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period. Circulation 2015;132:1726-33. doi: 10.1161/CIRCULATIONAHA.115.015721, PMID: 26416810; PMCID: PMC4816491

Ngene NC, Moodley J. Pre-eclampsia with severe features: Management of antihypertensive therapy in the postpartum period. Pan Afr Med J 2020;36:216. doi: 10.11604/pamj.2020.36.216.19895, PMID: 32963682; PMCID: PMC7490136

Published

07-10-2023

How to Cite

MISHRA, S., P. Kaur, and S. PAL KAUR. “EVALUATION AND MANAGEMENT OF POSTPARTUM HYPERTENSION IN A TERTIARY CARE HOSPITAL”. Asian Journal of Pharmaceutical and Clinical Research, vol. 16, no. 10, Oct. 2023, pp. 125-8, doi:10.22159/ajpcr.2023.v16i10.47925.

Issue

Section

Original Article(s)